ATRION Corporation
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $443.06
- Today's High:
- $457.66
- Open Price:
- $457.66
- 52W Low:
- $500
- 52W High:
- $703.2138
- Prev. Close:
- $452
- Volume:
- 2562
Company Statistics
- Market Cap.:
- $954.93 million
- Book Value:
- 135.591
- Revenue TTM:
- $176.36 million
- Operating Margin TTM:
- 19.23%
- Gross Profit TTM:
- $75.90 million
- Profit Margin:
- 17.01%
- Return on Assets TTM:
- 7.95%
- Return on Equity TTM:
- 12.37%
Company Profile
ATRION Corporation had its IPO on 1984-09-07 under the ticker symbol ATRI.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. ATRION Corporation has a staff strength of 722 employees.
Stock update
Shares of ATRION Corporation opened at $457.66 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $443.06 - $457.66, and closed at $446.99.
This is a -1.11% slip from the previous day's closing price.
A total volume of 2,562 shares were traded at the close of the day’s session.
In the last one week, shares of ATRION Corporation have slipped by -4.9%.
ATRION Corporation's Key Ratios
ATRION Corporation has a market cap of $954.93 million, indicating a price to book ratio of 4.5743 and a price to sales ratio of 5.7799.
In the last 12-months ATRION Corporation’s revenue was $176.36 million with a gross profit of $75.90 million and an EBITDA of $47.81 million. The EBITDA ratio measures ATRION Corporation's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, ATRION Corporation’s operating margin was 19.23% while its return on assets stood at 7.95% with a return of equity of 12.37%.
In Q1, ATRION Corporation’s quarterly earnings growth was a negative -58% while revenue growth was a negative 15.2%.
ATRION Corporation’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 31.1915
- PEG
- 0
Its diluted EPS in the last 12-months stands at $17.39 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into ATRION Corporation’s profitability.
ATRION Corporation stock is trading at a EV to sales ratio of 5.9638 and a EV to EBITDA ratio of 20.5871. Its price to sales ratio in the trailing 12-months stood at 5.7799.
ATRION Corporation stock pays annual dividends of $8.4 per share, indicating a yield of 1.61% and a payout ratio of 51.13%.
Balance sheet and cash flow metrics
- Total Assets
- $261.43 million
- Total Liabilities
- $17.17 million
- Operating Cash Flow
- $-77000.00
- Capital Expenditure
- $7.54 million
- Dividend Payout Ratio
- 51.13%
ATRION Corporation ended 2024 with $261.43 million in total assets and $0 in total liabilities. Its intangible assets were valued at $261.43 million while shareholder equity stood at $238.64 million.
ATRION Corporation ended 2024 with $0 in deferred long-term liabilities, $17.17 million in other current liabilities, 342000.00 in common stock, $377.38 million in retained earnings and $9.73 million in goodwill. Its cash balance stood at $4.56 million and cash and short-term investments were $17.58 million. The company’s total short-term debt was $0 while long-term debt stood at $0.
ATRION Corporation’s total current assets stands at $114.59 million while long-term investments were $8.70 million and short-term investments were $13.01 million. Its net receivables were $19.42 million compared to accounts payable of $16.11 million and inventory worth $75.09 million.
In 2024, ATRION Corporation's operating cash flow was $-77000.00 while its capital expenditure stood at $7.54 million.
Comparatively, ATRION Corporation paid $0.51 in dividends in 2024.
Other key metrics
- Current Trading Price
- $446.99
- 52-Week High
- $703.2138
- 52-Week Low
- $500
- Analyst Target Price
- $300
ATRION Corporation stock is currently trading at $446.99 per share. It touched a 52-week high of $703.2138 and a 52-week low of $703.2138. Analysts tracking the stock have a 12-month average target price of $300.
Its 50-day moving average was $519.75 and 200-day moving average was $582.88 The short ratio stood at 9.57 indicating a short percent outstanding of 0%.
Around 2278.3% of the company’s stock are held by insiders while 6475.4% are held by institutions.
Frequently Asked Questions About ATRION Corporation
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. The company’s fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company’s ophthalmic products consist of specialized medical devices that include disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.